Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

FDA Recall #D-0620-2024 — Class I — July 12, 2024

Recall #D-0620-2024 Date: July 12, 2024 Classification: Class I Status: Ongoing

Product Description

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Reason for Recall

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Recalling Firm

SoloVital — Chula Vista, CA

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

1,331 bottles

Distribution

Nationwide within the United States

Code Information

All lots within Expiry

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated